Back to News
Market Impact: 0.3
Mirum Pharmaceuticals Reports Q3 2026 Financial Results and Raises Full-Year Sales Guidance
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Mirum Pharmaceuticals reported quarterly revenue of $185.7 million for the quarter ended September 30, 2026, up from $133.0 million a year earlier (about 39.6%). Operating expenses were $245.5 million; the article text cuts off before giving the prior-year comparison or further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
MIRM0.35
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge